Epidural Anesthesia and Postoperative Analgesia With Ropivacaine and Fentanyl
Coronary Artery Disease

About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring Epidural Analgesia, OPCAB, PCEA
Eligibility Criteria
Inclusion Criteria:
- presence of coronary artery disease
- ASA II-III
- elective off-pump coronary artery bypass
Exclusion Criteria:
- age < 18 years
- severe valve dysfunction or peripheral vascular disease
- simultaneous interventions (carotid endarterectomy, aneurysm repair, etc.)
- transfer to CPB during surgery
Sites / Locations
- Dep. of Anesthesiology, Northern SMU
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
intravenous analgesia
epiduaral infusion
patient-controlled epidural analgesia
Patients received postoperative analgesia by intravenous fentanyl 10 µg/ml 3-8 mL/h.
Patients received epidural analgesia intraoperatively with ropivacaine 0.75% 1 mg/kg and fentanyl 1 µg/kg followed by continuous epidural infusion of ropivacaine 0.2% 3-8 mL/h and fentanyl 2 µg/mL postoperatively.
In addition to epidural anesthesia and epidural infusion, postoperatively patients received patient-controlled epidural analgesia with ropivacaine/fentanyl bolus 1 mL, lock-out interval 12 min.